Clinical Research Network

What Clinical Research Network does

Clinical Research Network (CRN) is a private US-headquartered operator of a clinical trial investigative site network, founded in 1993 and based in North Dartmouth. The company provides recruitment, retention, and quality assurance services through its network of clinical research trial sites, serving pharmaceutical and biotechnology sponsors that require site-based execution of Phase I–IV trials. CRN is positioned to support decentralized clinical trial designs, adaptive trial protocols, and digital patient engagement workflows — capabilities increasingly demanded by sponsors seeking faster enrollment and more flexible trial delivery models.

In terms of business model and operating footprint, CRN operates as a B2B clinical research services firm with an employee count of 11–50. No publicly disclosed pricing, contract structure, or revenue figures are available, and the company does not publish product-level detail beyond its core site-network service. Customer disclosures are absent, so the customer base is inferred to be concentrated in pharmaceutical and biotech sponsors contracting for trial execution; this segment is identified as CRN's primary use-case segment, with a horizontal segmentation approach across trial-phase and therapeutic-area needs.

In January 2025, Medical Research Network Limited — described as CRN's parent or affiliate — acquired the Volunteer Centre for Trials & Clinical Research (VCTC), explicitly to expand UK presence and strengthen decentralized clinical research capability. This is the most material strategic event in the available record and signals a transition from a primarily US-anchored site network toward a transatlantic footprint. Beyond this, the source set lacks verifiable detail on product portfolio, integrations, leadership, certifications, or financial performance, limiting the depth of inference. The company operates within a broader investigative site network market projected to reach $13.01 billion by 2030, providing structural tailwind, though CRN's specific share and competitive position within that market are not disclosed.

Name

Clinical Research Network

Website

https://crn-global.com

Company type

Private

Founded year

1993

Headcount range

11–50 employees

Short description

Clinical Research Network operates a US-based network of clinical trial investigative sites, offering recruitment, retention, and quality assurance services to pharmaceutical and biotechnology sponsors running Phase I–IV trials, with a growing UK footprint following its 2025 VCTC acquisition.

Ownership category

akta.pro rank

Product category

Clinical Research Site Network Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Clinical trial site network
• Clinical research services
• Patient recruitment services
• Decentralized clinical trials
• Clinical trial quality assurance

Headquarters

HQ city

North Dartmouth

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Core offering

Clinical Research Network operates an investigative clinical trial site network that provides patient recruitment, patient retention, and quality assurance services to clinical trial sponsors. The network is structured to support Phase I-IV trials and to enable decentralized trial designs, adaptive trial execution, and digital patient engagement. Its customers are primarily pharmaceutical and biotechnology companies conducting clinical research studies.

Product overview

Based on the available source data, no specific product names, modules, or detailed service descriptions could be extracted. The sources contain market trend analysis about the clinical trial investigative site network industry and mention Medical Research Network Limited's acquisition of Volunteer Centre for Trials & Clinical Research (VCTC), but do not provide information about Clinical Research Network's specific product portfolio, architecture, or individual offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Patient Recruitment Services Recruitment service line offered through CRN's investigative site network to help pharmaceutical and biotech sponsors identify and enroll patients into Phase I-IV clinical trials.
• Clinical Trial Patient Retention Services Retention service line offered through CRN's investigative site network to keep enrolled patients engaged through the duration of clinical trials, supporting decentralized and digitally enabled trial designs.
• Clinical Trial Quality Assurance Services Quality assurance service line delivered through CRN's investigative site network to support compliance and data integrity across Phase I-IV clinical trial execution.
• Investigative Site Network (Phase I-IV) The overarching investigative site network service offering, leveraging CRN's sites to execute Phase I-IV clinical trials for pharmaceutical and biotech sponsors, with capabilities supporting decentralized trial execution, adaptive trial designs, and digital patient engagement.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Volunteer Centre for Trials & Clinical Research (VCTC)coreStrategic or Co-development Partner · 1 January 2025Medical Research Network Limited (parent/affiliate of Clinical Research Network) announced acquisition of VCTC in January 2025 to expand UK presence and enhance decentralized clinical research capabilities. This acquisition strengthens the network's footprint in the UK market.

Scale indicators1 record

Recent moves1 record

Expansion highlights3 records

Direct peers

• Velocity Clinical Research: Velocity Clinical Research is an integrated site network operating multiple wholly-owned clinical trial sites across the US. It is the closest direct peer to CRN, offering similar recruitment, retention, and quality services to pharma and biotech sponsors across multiple therapeutic areas.
• Centricity Research: Centricity Research is an integrated research organization operating a multi-site clinical trial network across North America. It directly competes with CRN by offering sponsors access to dedicated research sites, patient recruitment, and decentralized trial capabilities.
• WCCT Global: WCCT Global operates a multi-site clinical trial network with strong early-phase and Phase I capabilities. It is directly comparable to CRN as a site network serving pharmaceutical and biotech sponsors with recruitment and trial execution services.
• Panthera Clinical Research: Panthera Clinical Research is a UK-based integrated site network operating dedicated clinical trial sites across the UK and Ireland. It is a direct peer given its overlap with CRN's UK footprint expansion via the VCTC acquisition.
• Flourish Research: Flourish Research is an integrated site network operating dedicated clinical trial sites primarily across the UK. It directly competes with CRN's UK operations in patient recruitment and Phase I–IV trial execution for pharma sponsors.
• Benchmark Research: Benchmark Research operates a multi-site clinical trial network across the United States. It directly competes with CRN for vaccine and therapeutic trial recruitment, offering similar Phase I–IV site services to sponsors.

Broad incumbents

• IQVIA: IQVIA is the world's largest CRO with significant site network and patient recruitment capabilities. It competes with CRN at the high end of the site network market, providing global reach that small site networks cannot match.
• Medpace: Medpace is a mid-to-large CRO with embedded site management and strong sponsor relationships. It competes for the same Phase II–III trial mandates that CRN targets, albeit at much greater scale.
• ICON plc: ICON plc is one of the largest global CROs, offering site management and clinical trial execution services across all phases. It competes with CRN for sponsor trial site activation and management contracts.

Emerging players

• Javara Inc. Javara is an integrated research organization partnering with healthcare systems to operate embedded clinical trial sites. It is an emerging player with a comparable site-network model to CRN but with a different go-to-market approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/crn2011
• LinkedInlinkedin.com/company/crn-clinical-research-network

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Research Network